Why the study?
To identify factors associated with adverse cardiovascular events in a cohort of patients with isolated non-compaction cardiomyopathy to identify high-risk patients.
In patients with isolated non-compaction cardiomyopathy, baseline NYHA class II, LVEF ≤50%, LV enlargement, reduced GLS, myocardial fibrosis, LBBB, and frequent PVCs are significant predictors of adverse cardiovascular events.
Answers are grounded in this paper and cite their sources.
Identified predictors may support risk stratification in isolated non-compaction cardiomyopathy; leaves open validation in prospective cohorts before guiding practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Комиссарова et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: